🔴 GeneDx is trading 4.5% down today alongside biotech’s 2.39% decline

GeneDx is trading at $65.93, down 4.53%, with biotech weakness offering a possible sector-level explanation.

• Biotech was down 2.39%; no GeneDx-specific headlines were listed for November 2.
• Third-quarter results are scheduled for November 9.
• Broad-market indices were higher, unlike GeneDx. No November 2 trading-volume figure was available in the reviewed source.